Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in ...

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen's Iqirvo® (elafibran ...

However, as the CTN path is preferred ... The MFDS (Ministry of Food and Drug Safety) offers a pre-investigational new drug (IND) submission consultation, which is advised prior to making the ...

As for the future, Mojsov is optimistic. She foresees a new generation of similar drugs that will further minimize side effects and target an even broader range of diseases.

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic ... Habener believed he could uncover new ways to manage diabetes.

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so what was that journey like for the scientists involved? Joel Habener of ...